No Data
No Data
No Data
No Data
No Data
Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation
Harbin Medisan Pharmaceutical's (SHE:002900) potassium chloride injection passed the consistency evaluation of China's National Medical Products Administration, the company said in its filing on the S
MT NewswiresApr 26 14:55
Kazakh Sanlian (002900.SZ): Net profit of 18.7895 million yuan in the first quarter decreased by 52.02% year-on-year
Gelonghui, April 25 | Harbin Sanlian (002900.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 247 million yuan, down 27.86% year on year; net profit attributable to shareholders of listed companies was 18.7895 million yuan, down 52.02% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 5.0845 million yuan, down 75.21% year on year; basic earnings per share were 0.06 yuan.
Gelonghui FinanceApr 25 17:06
Express News | Kazakh Triptych: Potassium chloride injection passed the consistency evaluation
BreakingsApr 25 16:25
Kazakh Triptych (002900.SZ): The first quarter report will be disclosed on April 26
Gelonghui, April 18, 丨 Kazanlian (002900.SZ) said on the investor interactive platform that the company's report for the first quarter of 2024 will be disclosed on April 26, 2024.
Gelonghui FinanceApr 18 15:42
The Kazakh trifecta staged the sky floor
The Kazakh trifecta fell to a standstill during the intraday period and staged a turnover of 485 million yuan.
Zhitong FinanceApr 18 14:51
Express News | Erlian Banha Triptych: There are no corrections or additions to the information disclosed by the company in the early stages
BreakingsApr 16 16:51
No Data
No Data